The role of cytokines in the evolution of cancer: IFN-γ paradigm

被引:23
|
作者
Todorovic-Rakovic, Natasa [1 ]
机构
[1] Inst Oncol & Radiol Serbia, Dept Expt Oncol, Pasterova 14, Belgrade 11000, Serbia
关键词
Immunoediting; IFN-gamma; Tumor-associated macrophages; Cancer progression; TUMOR-ASSOCIATED MACROPHAGES; INTERFERON-GAMMA; IMMUNE PRIVILEGE; PROSTATE-CANCER; BREAST-CANCER; CELL-DEATH; INFLAMMATION; EXPRESSION; MECHANISMS; RESPONSES;
D O I
10.1016/j.cyto.2021.155442
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The evolution of malignant cells implies an increase in oncogenic fitness of cells which arises in active and reciprocal interaction with the tumor microenvironment. The mechanisms facilitating the adaptive evolution of cancer cells involve clonal selection of cancer cells, in a direction of increased adaptive potential under the selective pressure of host defensive strategies. Once reached, this potential could go the other way, changing the same evolutionary force in the tumor microenvironment which influenced its emergence and favoring cancer progression. The immunological system as a part of host defensive mechanisms could be an effective modulator of cancer evolution/progression since it is also a major source of cellular intermediators, such as cytokines. The exemplar of IFN-gamma actions during cancer evolution could help the revealing of these mutual interactions and enable better insight into the complex nature of cancer disease, leading to a new approach to treatment strategies.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Independent origin of IFN-α and IFN-β in birds and mammals
    Hughes, AL
    Roberts, RM
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (08): : 737 - 739
  • [42] IFN-α and novel strategies of combination therapy for cancer
    Bracci, Laura
    Proietti, Enrico
    Belardelli, Filippo
    THYMOSINS IN HEALTH AND DISEASE: FIRST INTERNATIONAL SYMPOSIUM, 2007, 1112 : 256 - 268
  • [43] Empowering therapeutic antibodies with IFN-α for cancer immunotherapy
    Guo, Jun
    Xiao, Yu
    Iyer, Ramesh
    Lu, Xin
    Lake, Marc
    Ladror, Uri
    Harlan, John
    Samanta, Tanushree
    Tomlinson, Medha
    Bukofzer, Gail
    Donawho, Cherrie
    Shoemaker, Alex
    Huang, Tzu-Hsuan
    PLOS ONE, 2019, 14 (08):
  • [44] Impaired IFN-α production and the risk of cancer development
    Uno, Kazuko
    Hirosaki, Mayumi
    Kakimi, Kazuhiro
    Tominaga, Masumi
    Suginoshita, Yoshiki
    Hasegawa, Goji
    Fukui, Michiaki
    Nakamura, Naoto
    Shirakawa, Taro
    Kishidai, Tsunataro
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (12): : 1013 - 1017
  • [45] IFN-λ cancer immunotherapy: new kid on the block
    Lasfar, Ahmed
    Gogas, Helen
    Zloza, Andrew
    Kaufman, Howard L.
    Kirkwood, John M.
    IMMUNOTHERAPY, 2016, 8 (08) : 877 - 888
  • [46] IMPACT OF IFN-γ GENE ON THE RISK OF CERVICAL CANCER
    Tamandani, D. M. Kordi
    Sobti, R. C.
    Shekari, M.
    Mukesh, M.
    Suri, V.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3356 - 3357
  • [47] Regulation of tumor growth by IFN-γ in cancer immunotherapy
    Beatty, GL
    Paterson, Y
    IMMUNOLOGIC RESEARCH, 2001, 24 (02) : 201 - 210
  • [48] Regulation of tumor growth by IFN-γ in cancer immunotherapy
    Gregory L. Beatty
    Yvonne Paterson
    Immunologic Research, 2001, 24 : 201 - 210
  • [49] Modulation of IFN-γ Receptor 1 Expression by AP-2α Influences IFN-γ Sensitivity of Cancer Cells
    Chen, Changguo
    Guo, Liang
    Shi, Ming
    Hu, Ming
    Hu, Meiru
    Yu, Ming
    Wang, Tianyou
    Song, Lun
    Shen, Beifen
    Qian, Lu
    Guo, Ning
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (02): : 661 - 671
  • [50] INCREASED SERUM LEVELS OF IFN-Λ CORRELATE WITH TH17 AXIS CYTOKINES AND INDEPENDENTLY TO IFN-α IDENTIFY PATIENT GROUP WITH HIGHER ORGAN DAMAGE
    Oke, V.
    Brauner, S.
    Larsson, A.
    Gustafsson, J.
    Zickert, A.
    Gunnarsson, I.
    Svenungsson, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 128 - 128